Please login to the form below

Not currently logged in
Email:
Password:

Vikas Sinha joins Verona as non-executive director

Brings strong US and financial experience to the UK drug development firm

Verona Pharma Vikas SinhaUK drug development company Verona Pharma has appointed Vikas Sinha as a non-executive director.

Currently executive vice president and chief financial officer at Alexion Pharmaceuticals, Sinha has served at the rare disease firm since 2005.

Prior to that he spent 11 years at Bayer, holding roles in the US, Canada, Japan and Germany, latterly as chief financial officer for Bayer Pharmaceuticals Corporation in the US.

Dr David Ebsworth, chairman of Verona Pharma, said: “Vikas' impressive financial background, including his US expertise, makes him a very welcome addition to our Board of Directors. 

“I have known Vikas for many years having worked together at Bayer and hold his impressive track record in high regard. We are pleased that Vikas will be joining our Board at such a pivotal time, as we progress our lead asset, RPL554, into a phase IIb clinical trial programme.”

A potential first-in-class treatment for chronic obstructive pulmonary disease (COPD), Verona Pharma's RPL554 is being tested as a nebulised maintenance treatment for patients with moderate to severe disease.

13th September 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics